theheart.org: Interventional Surgery news and studies. Duke and Mayo partnership.

The selected article could not be found. Try again later or contact administrator.

Interventional/Surgery

Baseline function data from STICH no help in pinpointing patients who benefit from SVR

Nov 18, 2009 10:45 EST

Measures of left ventricular dysfunction or wall motion identified by different imaging modalities at baseline offer no clues as to whether a subset of patients treated with surgical ventricular reconstruction might benefit from the procedure.

Orlando, FL - Heaping on the disappointment, a new substudy from the Surgical Treatment for Ischemic Heart Failure (STICH) trial has failed to find a subgroup that benefits from surgical ventricular reconstruction (SVR), a least on the basis of left ventricular (LV) function at the time of study enrollment. Read full article »

Inside: Interventional/Surgery

Accredited educational programs, supported by industry, developed by theheart.org

Interventional/Surgery

PCI in Left Main Disease: Are We There Yet?

1 COMMENT - Nov 11, 2009 11:41 EST

SYNTAX and MAIN-COMPARE suggest a role for PCI in subsets of patients with left main disease; however, in current ACC/AHA guidelines this remains a class III indication. Dr. Turco chairs a roundtable with interventionalists Drs Kandzari and Park and surgeon Dr Sabik.

Interventional/Surgery

Revascularization in Patients With Diabetes

Oct 7, 2009 14:12 EDT

Since BARI, CABG has been the gold standard for patients with diabetes and multivessel disease. However, SYNTAX suggests an increasing role for PCI and BARI 2D highlights the importance of optimal medical therapy. Dr. Boden leads a multidisciplinary discussion with Drs. Holmes and Taggart.

Interventional/Surgery

Emerging Stent Technologies: Adding Innovation and New Science to Clinical Practice

Oct 20, 2009 13:38 EDT

Dr. Dean Kereiakes leads an international panel of experts, Drs. Meredith, Banning, and Hermiller, as they discuss fascinating developments in stent and polymer technology and design their "dream stent."

Interventional/Surgery

There's Triple Vessel Disease and Triple Vessel Disease: Risk Assessment

2 COMMENTS - Jun 22, 2009 08:08 EDT

How do the results of the SYNTAX trial impact clinical practice now? Join Drs. Banning and Hill as they present a complex case taken directly from the SYNTAX trial and discuss how new data will impact their choice of treatment, and listen to an overview of the trial presented by Dr. William Wijns.

Interventional/Surgery

TAVI vs AVR Patient Selection

Oct 27, 2009 14:49 EDT

The PARTNER and PAVIS trials of transcatheter aortic valve implementation will include inoperable or very high-surgical-risk patients. In Europe, where the devices have been approved for a few years, the technology is being expanded to lesser-risk patients. Interventionalist Dr Jeffrey Popma discusses the selection of patients with surgeon Dr Mathew Williams.

Interventional/Surgery

Transcatheter Aortic Valves: Lessons From Europe

Jun 26, 2009 00:02 EDT

Transcatheter aortic valve implantation (TAVI) has been approved in Europe since 2007, whereas these devices are just entering large-scale research trials in the United States. Dr. Popma leads a panel discussion with European interventionalist Dr. Eberhard Grube and surgeon Dr. Neil Moat on their experiences with TAVI.

Interventional/Surgery

Drug-Eluting Stents: Head-to-Head Clinical Trial Results

Oct 16, 2009 11:06 EDT

How do drug-eluting stents compare? Our panel of experts, Drs. Stone, Kereiakes, Serruys, and Windecker discuss the late-breaking trials at TCT 2009 of DES vs DES.

Clinical cardiology

New Data on Polyvascular Disease and ACS

1 COMMENT - Jun 23, 2009 09:40 EDT

Recently published data suggest that prior polyvascular disease increases the risk for inhospital adverse events in patients with ACS. Join Drs. Deepak Bhatt, Jean-Pierre Bassand, and José R. Gonzalez-Juanatey for a discussion of the current data on identification and management of patients with polyvascular disease.

Clinical cardiology

Combination Therapy and Cardiovascular Events: A Neurologist's Perspective

1 COMMENT - Jun 17, 2009 11:48 EDT

AF can lead to stroke, congestive heart failure, and other serious complications. Successful management should include reducing these risks. Join our expert panel, Drs. Peter Rothwell, Donald Easton, and Mark Alberts, as they discuss new data and strategies for improving outcomes in patients with AF.

Clinical cardiology

2009 Antiplatelet Debate: What's New in ACS

6 COMMENTS - Jun 12, 2009 15:03 EDT

Despite modern therapy, the rates of death, MI, bleeding, and readmission remain high in patients with ACS. Join Drs. Jeffery Popma, Héctor Bueno, Freek Verheugt, and Sunil. Rao for a review of the latest data on antiplatelet therapy for patients with ACS.

Interventional/Surgery

Variable Rate Contrast Injection in the Cath Lab

7 COMMENTS - May 11, 2009 10:00 EDT

Variable rate contrast delivery systems have the potential to improve workflow and patient outcomes by providing a more precise flow of contrast. Watch Dr. Jeffrey Moses and his team as they demonstrate the use of the device in the cath lab in a patient with complex lesions.

heartbriefs

Sen Grassley questions top medical schools about ghostwriting

Nov 20, 2009 13:15 EST

As part of his mission to see more financial transparency in medicine, Sen Grassley has asked eight top US medical schools about their policies on ghostwriting.

Medscape Medical News

Stroke incidence related to PCI steady over 15 years

2 COMMENTS - Nov 20, 2009 13:00 EST

Mayo Clinic researchers report that their stroke rate related to PCI has stayed steady for the last 15 years, something they interpret as good news, given that substantially older, sicker patients with more complex anatomy are now undergoing PCI.

Top Story

Oral anticoagulants REDEEMed? Daily dabigatran "safe" with dual antiplatelets after MI

Nov 19, 2009 11:00 EST

A dose-finding study saw what were characterized as low bleeding rates associated with triple-drug antithrombotic therapy that included the oral anticoagulant dabigatran in patients with a recent ACS event and other cardiovascular risk factors.

News

EFFECT: Public reporting of hospital performance improves quality of care?

Nov 19, 2009 10:00 EST

Publicly released report cards based on hospital performance did not result in a measurably greater systemwide improvement in two composite AMI or CHF process-of-care indicators in a Canadian study. But they did appear to stimulate some important changes in delivery of care that could have led to some better outcomes.

Interventional/Surgery

BARI 2D cost-effectiveness analysis favors medication over PCI for less severe CVD in diabetic patients

1 COMMENT - Nov 18, 2009 15:45 EST

New data from the BARI 2D trial comparing medical therapy vs revascularization in diabetics shows higher up-front costs of revascularization are only partially offset by long-term savings.

Thrombosis Risk

Ticagrelor effects unraveled in new phase 2 trials

Nov 18, 2009 15:00 EST

New and unique phase 2 data add to the growing body of evidence explaining the pharmacologic effects of the new antiplatelet agent ticagrelor.

Acute Coronary Syndromes

ACC/AHA focused update of guidelines for STEMI, PCI

10 COMMENTS - Nov 18, 2009 09:00 EST

The latest evidence for the treatment of STEMI and PCI has been incorporated into a fast-track update of US guidelines. But questions remain about the quality of some of the evidence informing the guidelines and about the composition of the writing committees.

Interventional/Surgery

POPE: No benefit of diclofenac on pericardial effusion

Nov 17, 2009 10:00 EST

Mean pericardial effusion grade postcardiac surgery was not reduced with 14 days of treatment with the NSAID.

Interventional/Surgery

CASCADE: No significant benefit of clopidogrel in reducing graft disease after CABG

4 COMMENTS - Nov 17, 2009 09:00 EST

Dual antiplatelet therapy did not significantly reduce vein graft intimal hyperplasia compared with aspirin alone over 12 months.

Heart failure

HeartMate II continuous-flow VAD sets new benchmark in destination-therapy trial

Nov 17, 2009 08:00 EST

UPDATED WITH COMMENTARY // Thoratec's HeartMate II continuous-flow VAD keeps about half of patients alive and stroke- or reintervention-free after two years in pivotal destination therapy trial.

Brain/Kidney/Peripheral

Bypassing the blues: How simple collaborative care can help tackle depression after CABG surgery

Nov 16, 2009 18:45 EST

Depression after coronary artery bypass surgery is often overlooked by physicians but is associated with worse outcomes. A new US study illustrates a simple telephone-based approach to tackle this, with nurses encouraging patients to seek help from their primary-care doctors and providing ongoing feedback and review.

View all »

Editorial Programs

Editorial series

Life and times of leading cardiologists with Rob Califf. Guest: Bob Harrington

3 COMMENTS - Nov 6, 2009 09:50 EST

Raised in a blue-collar neighborhood of Somerville, MA, Dr Bob Harrington was blessed to have a strong family and the Jesuits on his side as he traveled from "Yankee" Boston to Duke University. Join him as he tells his story to Dr Rob Califf.

Editorial series

Clinical research: Comparing regulatory pathways in US and UK

Oct 30, 2009 12:35 EDT

How do regulatory pathways differ in the US and UK? Drs Harrington, Bhatt, and Cleland share their experiences and offer insight on how to support innovative research.

Editorial series

Life and times of leading cardiologists with Rob Califf. Guest: Peter Sleight

2 COMMENTS - Oct 13, 2009 10:15 EDT

With the ISIS-1 trial, Dr Peter Sleight and his team at Oxford changed the approach to cardiovascular research. Join Dr Robert Califf as he talks to Dr Sleight about his journey from London to San Francisco to Oxford and finally to Italy, where he discovered the music of the heart.

	Yes
	No